Neurocrine Biosciences (NBIX) Misses Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 142.57 -0.72 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.29 | 52 Week High | $58.46 | |||
| Open | $142.74 | 52 Week Low | $31.25 | |||
| Day High | $143.83 | P/E | N/A | |||
| Day Low | $140.90 | EPS | $-0.69 | |||
| Volume | 377,621 | |||||
